Molecular and Epigenetic Biomarkers in Luminal Androgen Receptor: A Triple Negative Breast Cancer Subtype

OMICS. 2016 Oct;20(10):610-613. doi: 10.1089/omi.2016.0029. Epub 2016 Jun 21.

Authors

Gaëlle Judes^{1

2}, Aslihan Dagdemir^{1

2}, Seher Karsli-Ceppioglu^{1

2

3}, André Lebert⁴, Marie-Mélanie Dauplat^{2

5}, Khaldoun Rifaï^{1

2}, Marine Daures^{1

2}, Lucas Dubois^{1

2}, Yves-Jean Bignon^{1

2}, Frédérique Penault-Llorca^{2

5}, Dominique Bernard-Gallon^{1

2}

Affiliations

¹ 1 Department of Oncogenetics, Centre Jean Perrin , CBRV, Clermont-Ferrand, France .
² 2 EA 4677 "ERTICA, " University of Auvergne , Clermont-Ferrand, France .
³ 3 Department of Toxicology, Faculty of Pharmacy, Marmara University , Istanbul, Turkey .
⁴ 4 University Blaise Pascal , Pascal Institute UMR 6602 CNRS/UBP, Aubière, France .
⁵ 5 Laboratory of Biopathology, Centre Jean Perrin , Clermont-Ferrand, France .

PMID: 27326890
DOI: 10.1089/omi.2016.0029

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers, Tumor / genetics*
Biomarkers, Tumor / metabolism
Cell Line, Tumor
Epigenesis, Genetic*
Genetic Markers
Humans
Immunohistochemistry
Receptors, Androgen / genetics*
Receptors, Androgen / metabolism
Transcriptome / genetics
Triple Negative Breast Neoplasms / genetics*

Substances

Biomarkers, Tumor
Genetic Markers
Receptors, Androgen